Treatment of long bone non-union with demineralized bone matrix: a systematic review
British Medical Bulletin · 05.10.2026 · 160 (1)
DOI: 10.1093/bmb/ldag040 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift British Medical Bulletin, online erschienen am 30.10.2026. Verfasst von Ryan N McIlwain und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, University of Alabama at Birmingham, Faculty Office Tower 1105B, 510 20th Street South, Birmingham, AL 35233, Unit…. Hauptthemen laut MEDLINE: Fractures, Ununited, Bone Matrix, Bone Transplantation. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background Non-union is a challenging complication following long bone fractures. Demineralized bone matrix (DBM) has been increasingly utilized, however, its role in managing long bone non-union remains unclear. This systematic review evaluates the published research on the effectiveness of DBM in treating long bone non-union. Sources of data Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, PubMed, Embase, and Scopus were searched from inception to March 2026 for studies assessing DBM use in adult long bone non-union. Areas of agreement Eight studies including 340 patients were included. DBM was used alone or combined with autologous bone marrow concentrate (BMC), platelet-rich fibrin (PRF), platelet-rich plasma (PRP), or cancellous allograft chips. Union rates were similar when comparing DBM and iliac crest bone grafting (ICBG). DBM-treated patients achieved 79%–100% union (mean time to union between 3.7 and 11.9 months) versus 80%–100% for ICBG. Complications were minimally reported with no DBM-specific adverse events. Areas of controversy Significant heterogeneity existed in DBM formulation, volume, and administration strategies. Studies utilized putty, strips, and injectable formulations, with volumes ranging 1–10 cc. DBM was also variably combined with PRP, BMC, or cancellous allograft chips. Outcome reporting was not standardized. Growing points DBM appears to be an effective grafting strategy across diverse clinical applications and may offer a viable alternative to autologous grafting. Areas timely for developing research Further high-quality randomized controlled trials with consistent outcome measures are needed to define optimal use of DBM in treating long bone non-union.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, University of Alabama at Birmingham, Faculty Office Tower 1105B, 510 20th Street South, Birmingham, AL 35233, United States.
ORCID-Profile: Ryan N McIlwain, Elizabeth R Powell, Robin M Litten, Alexis N Alders, Joey P Johnson
Zitieren
APA
McIlwain, R. N., Powell, E. R., Litten, R. M., Alders, A. N., & Johnson, J. P. (2026). Treatment of long bone non-union with demineralized bone matrix: a systematic review. British Medical Bulletin, 160(1). https://doi.org/10.1093/bmb/ldag040
Vancouver
McIlwain RN, Powell ER, Litten RM, Alders AN, Johnson JP. Treatment of long bone non-union with demineralized bone matrix: a systematic review. British Medical Bulletin. 2026;160(1). doi:10.1093/bmb/ldag040
BibTeX
@article{McIlwain2026,
author = {McIlwain, Ryan N and Powell, Elizabeth R and Litten, Robin M and Alders, Alexis N and Johnson, Joey P},
title = {Treatment of long bone non-union with demineralized bone matrix: a systematic review},
journal = {British Medical Bulletin},
year = {2026},
volume = {160},
number = {1},
doi = {10.1093/bmb/ldag040}
}
EUVIMED